Alerpharma Overview

  • Status
  • Acquired/​Merged
  • Employees
  • 39
Employees
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Alerpharma General Information

Description

Developer of an immunology therapy and vaccines for allergy. The company has developed immunology therapy vaccines, bacteriological vaccines and diagnostics which is used in treating bacterial infections and allergies.

Contact Information

Website
www.inmunal.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • Parque Cientifico Tecnologico
  • Alcala de Henares
  • Spain
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Alerpharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Alerpharma‘s full profile, request access.

Request a free trial

Alerpharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial